Validation of stricture length, duration and obstructive symptoms as predictors for intervention in ileal stricturing Crohn's disease. Issue 9 (7th December 2022)

• Record Type: Journal Article
• Authors: El Ouali, Sara; Baker, Mark E.; Lyu, Ruishen; Fletcher, Joel G.; Bruining, David H.; Holubar, Stefan D.; Click, Benjamin; Qazi, Taha; Cohen, Benjamin L.; Rieder, Florian
• Is Part Of: United European Gastroenterology journal. Volume 10:Issue 9(2022)
• Page Start: 958
• Page End: 972
• Publication Date: 2022-12-07
• Subjects: Crohn's disease -- dilation -- intervention -- stricture -- surgery; Gastroenterology -- Periodicals; Periodicals; 616.33005
• DOI: 10.1002/ueg2.12314
• Languages: English
• ISSNs: 2050-6406

Abstract

Abstract: Background: Risk factors for intervention in terminal ileal (TI) stricturing Crohn's disease (CD) are poorly defined. Novel and rigorous definitions for TI strictures recently became available. Objective: We aimed to describe the rates of symptoms or need for endoscopic balloon dilation (EBD) or surgery as well as risk factors of progression in a well‐defined stricturing CD cohort. Methods: Consecutive adult patients with non‐penetrating stricturing TI CD, as defined by centrally‐read magnetic resonance enterography CONSTRICT criteria, were separated into a derivation and validation cohort. Clinical and imaging characteristics were collected following prespecified scoring conventions. Primary outcome was a composite endpoint of EBD or surgery ("intervention"). Multivariable analysis was performed. Results: Eighty‐six patients (48.8% female, median age 36 years) met selection criteria, 17.4% had prior EBD, 59.3% previously received biologics and 58.1% of strictures were anastomotic. Median follow‐up was 63.4 [95% CI: 57, 68.9] months. In the derivation cohort, at 12 and 48 months, 26% and 45% of patients had intervention, respectively. Multivariable analysis showed obstructive symptoms (Hazard ratio [HR] 1.444; 95% CI 1.126–1.852), stricture duration (HR 0.974; 95% CI, 0.954–0.995) and length (HR 1.039; 95% CI, 1.011–1.069) predicted intervention. The concordance index for split‐sample validation was 0.74 and 0.67, respectively. Biologics were not associated with intervention. An online risk calculator was constructed. Conclusion: In patients with TI stricturing CD, 26% and 45% required intervention at 1 and 4 years. Obstructive symptoms, stricture duration and length were independent and validated predictors of the need for intervention. These findings are important for clinical practice and aid in the design of future trials for CD strictures.